Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
28S ribosomal protein S16, mitochondrial (MRPS16), is a nuclear-encoded protein crucial for the assembly and function of the mitochondrial small ribosomal subunit (28S)[1][6]. Unlike prokaryotic ribosomes, mammalian mitoribosomes have distinct protein-to-RNA ratios and lack some rRNA components. MRPS16 is highly conserved, especially between yeast and mammalian mitochondria, reflecting its essential role in mitochondrial protein synthesis. It participates in the translation of mitochondrial-encoded proteins necessary for oxidative phosphorylation, the process by which mitochondrial energy is generated[1][5]. Mutations in MRPS16 disrupt mitochondrial translation and lead to severe multisystem mitochondrial diseases, including combined oxidative phosphorylation deficiency 2 (COXPD2), and have been linked to lethal neonatal syndromes involving lactic acidosis and neurological deficits[2][5]. MRPS16 is not a classical therapeutic target, but it is essential for cellular energy metabolism and mitochondrial function.
Not applicable; MRPS16 is not a direct drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 28S ribosomal protein S16, mitochondrial (MRPS16).